Infectious Disease Control

More Than 9 in 10 Surgeons Encounter a Needlestick Injury, New Global Survey Finds

LONDON, Sept. 20, 2019 /PRNewswire/ --   * 81% believe high quality gloves impact patient outcomes; * 92% agreed high quality gloves improve safety of clinicians; * Survey demonstrates importance surgeons place on high quality gloves in protecting against infection and patient safety; * F...

2019-09-20 07:00 453

Tahir Foundation launches new partnership to end malaria in Indonesia

JAKARTA, Indonesia, Aug. 22, 2019 /PRNewswire/ -- In a joint partnership, the Tahir Foundation and the Asia Pacific Leaders Malaria Alliance (APLMA)[1]  announced the launch of M2030 inIndonesia. Started by APLMA in 2018, M2030[2] is a movement that brings together businesses, consumers and ...

2019-08-22 08:00 1532

KT Corp. Unveils Global Epidemic Prevention Platform in Ghana

* KT-Ghana Deal Is First GEPP Service Outside Korea * Ghana Will Upgrade Capacity to Handle Infectious Diseases * KT Technologies Address Global Human Welfare Issues SEOUL, South Korea, Aug. 18, 2019 /PRNewswire/ -- KT Corp. (KRX: 030200; NYSE: KT) said its Global Epidemic Prevention Platfor...

2019-08-18 17:00 3895

binx health Receives FDA 510(k) Clearance For Rapid Point Of Care Platform For Women's Health

binx io enables first-ever "test-and-treat" paradigm with sample to answer in 30 minutes for the two most tested-for sexually transmitted infections (STIs) BOSTON, Aug. 12, 2019 /PRNewswire/ --  binx health, the pioneer in anywhere, anytime testing for women's health, today announced that it has ...

2019-08-12 20:30 1919

Corteva Agriscience Launches in Myanmar to Serve Farmers Better with the Newest Innovation in Seed and Crop Protection Technologies

YANGON, Myanmar, Aug. 7, 2019 /PRNewswire/ -- Pure-play global agriculture leader, Corteva Agriscience (NYSE:CTVA), has officially launched its brand in Myanmar. In conjunction with the brand launch, the company also introduced Zorvec® Encantia® fungicide - a new international award-winning diseas...

2019-08-07 10:30 7033

Penta and CROMSOURCE Announce Their Partnership to Improve Paediatric Drug Development

VERONA, Italy, July 25, 2019 /PRNewswire/ -- Penta ID Innovation, a recently established SMO stemmed from the Penta Global Paediatric Research Network, and CROMSOURCE, an international contract research organization (CRO) providing a comprehensive portfolio of services to the pharmaceutical, biot...

2019-07-25 19:00 1872

Belgian Meat Office: African Swine Fever: How Belgium Successfully Keeps Its Pork Virus-Free

Belgium deals well with the outbreak of African swine fever (ASF) in September 2018. That is the conclusion of European ASF experts. Belgium succeeds in keeping domestic pigs and captive wild pigs free of ASF contamination -- thus keepingall its pork virus-free and suitable for consumption and ex...

2019-07-10 13:00 1632

Singapore Health Sciences Authority Approves Vosevi(R) (Sofosbuvir/ Velpatasvir/ Voxilaprevir) for Re-treatment of Adults with Chronic Hepatitis C Virus

SINGAPORE, June 24, 2019 /PRNewswire/ -- Gilead Sciences, Inc. today announced that the Singapore Health Sciences Authority has approved Vosevi (sofosbuvir 400mg/velpatasvir 100mg/voxilaprevir 100mg), a once-daily single tablet regimen for the re-treatment of adults with genotype 1-6 chronic hepa...

2019-06-24 14:00 1641

Livestock Philippines 2019 Exhibition Postponed On Instruction of the Department of Agriculture due to Concerns of African Swine Fever

MANILA, Philippines, June 24, 2019 /PRNewswire/ -- The Department of Agriculture has implemented tightened quarantine controls as one of its strategies since the outbreak started last year. As a result, the Department and the local swine industry have raised the possibility of ASF entering the c...

2019-06-24 12:26 1046

Experts Discuss Decentralized Manufacturing to Tackle Neglected Tropical Diseases and Promote Universal Health Coverage at World Health Assembly Event

- Global health leaders covered biomanufacturing and neglected tropical diseases (NTDs) during 72nd World Health Assembly - Event focused on innovative science and technology-based solutions to increase access to medicines and biologics DARMSTADT, Germany, May 22, 2019 /PRNewswire/ -- Merck, a ...

2019-05-22 20:00 1425

Inovio First to Advance Lassa Fever Candidate Vaccine Into a Clinical Trial

Subjects dosed in First-in-Human study of INO-4500 funded by the Coalition for Epidemic Preparedness Innovations Planned for emergency use as a stockpiled vaccine PLYMOUTH MEETING, Pa. and OSLO, Norway, May 21, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO), together with CEPI, ...

2019-05-21 21:00 2182

Merck Joins TRANSVAC2 Program to Advance Vaccine Development and Manufacturing

- TRANSVAC2, part of the EU's Horizon 2020 program, provides trainings to streamline vaccine manufacturing and development - Merck to offer its M Lab™ Collaboration Center in Molsheim, France for process development skills training DARMSTADT, Germany, May 20, 2019 /PRNewswire/ -- Merck, a leadin...

2019-05-20 20:00 1269

Inovio and Plumbline Life Sciences Establish Animal Health Collaboration to Develop A Novel Vaccine Against Deadly African Swine Fever Virus

PLYMOUTH MEETING, Pennsylvania and SEOUL, South Korea, May 15, 2019 /PRNewswire/ -- Inovio Pharmaceuticals Inc. (NASDAQ: INO) and Plumbline Life Sciences (XKRX: 222670) today announced a collaboration to co-develop a novel animal health vaccine for African swine fever (ASF) virus. The vaccine...

2019-05-15 21:00 1167

binx health Receives CE Mark For Rapid Chlamydia And Gonorrhea Test For Mass Markets

Multiplex Test Panel for binx io® Point-of-Care Platform Positioned to Radically Reduce Time to Treatment, Expand Access to Care BOSTON, May 2, 2019 /PRNewswire/ -- binx health™, the pioneer in anywhere care today announced that its proprietary Chlamydia and Gonorrhea (CT/NG) test has received E...

2019-05-02 03:11 601

Global Business Leaders Join Forces to End Malaria in Asia - Pacific

BANGKOK, April 26, 2019 /PRNewswire/ -- Today, the Asia Pacific Leaders Malaria Alliance (APLMA) and the World Economic Forum announced the M2030 Champions Council. Consisting of CEOs and Presidents from some of the most far-reaching businesses inAsia-Pacific, as well as leaders from the publi...

2019-04-26 11:00 749

Malaria Week: "United, We Will Defeat Malaria in Asia-Pacific"

BANGKOK, April 25, 2019 /PRNewswire/ -- Today, representatives from 24[i] Asia-Pacific nations pledged to undertake collective action to accelerate progress against malaria and eliminate the disease in the region for good. Hosted by the Government of Thailand, Malaria Week 2019

2019-04-25 10:00 697

PrimeStore® MTM opens Sputum-free Molecular Screening for M. tuberculosis Infection

South Africa pilot study demonstrates new broad approach to identifying M. tuberculosisinfected patients for further clinical investigation and treatment BETHESDA, Maryland, April 23, 2019 /PRNewswire/ -- The results of a pilot study using Longhorn Vaccines and Diagnostics's patented sample coll...

2019-04-23 21:00 381

PATH and MMV launch 5-year global initiative to support elimination of relapsing malaria

GENEVA and SEATTLE, April 23, 2019 /PRNewswire/ -- PATH and Medicines for Malaria Venture (MMV) announce a 5-year, jointly-led initiative,VivAccess, to support countries in the elimination ofPlasmodium vivax (P. vivax) malaria. The initiative is part of the larger global effort to support malaria...

2019-04-23 14:00 361

First Light Diagnostics Commended by Frost & Sullivan for its MultiPath™ Platform for Infectious Disease Management

MultiPath™ is an efficient platform for infection diagnoses and provides rapid antimicrobial susceptibility testing that radically reduces time and healthcare costs SANTA CLARA, California, April 17, 2019 /PRNewswire/ -- Based on its recent analysis of the North American rapid diagnostics market...

2019-04-17 20:00 431

Shifting Focus to Preventive Healthcare Unleashes New Revenue Opportunities for Infectious Disease Point-of-Care-Testing

Enhanced connectivity capabilities and vendor-agnostic solutions to drive next-generation POCT, finds Frost & Sullivan LONDON, Feb. 5, 2019 /PRNewswire/ -- The European infectious disease  point-of-care-testing (POCT) market, presently worth $753.1 million, is expected to grow to$1.41 billion by ...

2019-02-05 01:32 990
12345 ... 13